stockhead on MSN6h
Biocurious: Island Pharmaceuticals’ two-pronged plan to put the mozz on dengue feverJapan’s Takeda recently withdrew its US Food & Drug Administration (FDA) approval application for another vaccine, Qdenga ...
Golf is hitting the home stretch with the four main tours in action. Rory McIlroy leads the field in Abu Dhabi in the first ...
The Loop on MSN12h
Charley Hull’s (forced) cig break, Nelly Korda’s SI Swimsuit nod and Bryson DeChambeau’s big-man-on-campus moveBut he still followed along in a golf cart with the former President, teammate Saquon Barkley (Did Barack teach Saquon that ...
Report on how AI is redefining market landscape - The global gastroparesis drugs market size is estimated to grow by USD 1.42 ...
Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced the appointment of Claudia Lopez, DVM, MSc, as its new. Dr. Lopez brings more than two decades of clinical ...
With a mix of breakout sessions, hands-on workshops, and in-depth discussions, learning from real-world case studies that ...
Prediabetes market size is estimated to reach USD 360.6 million by the end of 2032. The industry growth is driven by the ...
Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that final data from the Phase 2 REVIVE study with rusfertide in polycythemia vera will be the focus of a poster presentation ...
Stifel has upgraded Alkermes (ALKS) to buy from hold, citing increased confidence in the company’s narcolepsy drug candidate ALKS2680. Read more here.
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate UpdateACI-7104.056 VacSYn Phase 2 trial in Parkinson’s disease ...
following positive recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback